We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

3 hedge funds and large institutions have $2.9K invested in Infinity Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% less funds holding

Funds holding: 45 → 3 (-42)

95% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 44

100% less capital invested

Capital invested by funds: $4.23M → $2.9K (-$4.23M)

Holders
3
Holders Change
-42
Holders Change %
-93.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
44
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$24K
2
HCM
Highlander Capital Management
New Jersey
+$464

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$1.34M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$838K
3
SFM
Sphera Funds Management
Israel
-$311K
4
BlackRock
BlackRock
New York
-$308K
5
CC
Carlson Capital
Texas
-$274K
Name Holding Trade Value Shares
Change 		Change in
Stake
LFAS
26
Level Four Advisory Services
Texas
– -$7.47K -35,500 Closed
VF
27
Virtu Financial
New York
– -$7K -34,545 Closed
Bank of New York Mellon
28
Bank of New York Mellon
New York
– -$7.2K -34,188 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– -$5.41K -25,649 Closed
Wells Fargo
30
Wells Fargo
California
– -$5K -23,750 Closed
YIH
31
Y-Intercept (HK)
Hong Kong
– -$4.81K -22,849 Closed
Group One Trading
32
Group One Trading
Illinois
– -$2.98K -14,150 Closed
Ameriprise
33
Ameriprise
Minnesota
– -$2.97K -14,100 Closed
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
– -$2.32K -11,008 Closed
MML Investors Services
35
MML Investors Services
Massachusetts
– -$2K -10,741 Closed
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
– -$1.54K -7,328 Closed
CB
37
Community Bank
New York
– -$1.26K -6,000 Closed
PA
38
PSI Advisors
Florida
– -$737 -3,500 Closed
National Bank of Canada
39
National Bank of Canada
Quebec, Canada
– -$520 -2,600 Closed
Osaic Holdings
40
Osaic Holdings
Arizona
– -$286 -1,364 Closed
JP Morgan Chase
41
JP Morgan Chase
New York
– -$244 -1,160 Closed
Bank of America
42
Bank of America
North Carolina
– -$159 -758 Closed
UBS Group
43
UBS Group
Switzerland
– -$126 -600 Closed
NSIM
44
North Star Investment Management
Illinois
– -$66 -315 Closed
HCM
45
Highlander Capital Management
New Jersey
– +$464 +3,500 New
1
2

INFI Hedge Fund Activity: Q3 2023 in Review

3 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q3 2023, worth a combined $2.9K — down 100% from $4.23M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of INFI and 2 opened new positions — a net loss of 42 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was XTX Topco, opening a new position worth an estimated $24K. The largest seller was BVF Inc, exiting entirely with an estimated $1.34M sold.

  • 3 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q3 2023, down from 45 in Q2 2023.
  • Funds reported $2.9K of Infinity Pharmaceuticals, Inc. stock for Q3 2023, down 100% quarter-over-quarter.
  • 2 funds opened new Infinity Pharmaceuticals, Inc. positions in Q3 2023 and 44 closed out, a net change of -42 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q3 2023 was XTX Topco, an estimated $24K added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q3 2023 was BVF Inc, an estimated $1.34M sold.

Based on aggregated 13F filings for Q3 2023.